Latest Breaking News On - Downing ventures - Page 8 : comparemela.com
Israel s DiA gets $14M to expand AI-driven ultrasound analysis – TechCrunch
techcrunch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techcrunch.com Daily Mail and Mail on Sunday newspapers.
VC Daily: Remote Work Boosts Blogging Platform; New Tech-Industry Battle Is Taking Shape; China Set to Pass Strict Data-Privacy Law
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Vote now: Most Influential Woman in UK Technology 2021
computerweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from computerweekly.com Daily Mail and Mail on Sunday newspapers.
Results for
Launch of new VC club strengthens Israel-UK business relations
Backed by the British Embassy, the new Israel-UK investor Hub will facilitate information sharing between VCs from both countries, and lead to more investments for Israeli startups Dor Schwartz / 11 May 2021 • 3 min read
Israel has long been a global resource for innovation, though over the past year, Israeli tech and talent demand has skyrocketed to new levels; multinational corporations establishing R&D presence and cloud region in the country, the chip wars, and you can’t forget the massive amounts of funding flowing into the Israeli startup ecosystem. All of this activity has highlighted a need for strong business networking in the “Scale-Up Nation”.
Invizius Limited, a Motherwell, Scotland, UK-based biotechnology company developing treatments to suppress unwanted innate immune responses, closed Series A financing of £5.3m.
The round was led by existing investors Mercia, Downing Ventures, Old College Capital, Scottish Enterprise, Solvay Ventures and new investors Calculus Capital and experienced life science entrepreneur and investor, Dr Jonathan Milner. The Series A remains open to other investors until June 2021.
The company intends to use the funds to complete a First-in-Man safety study in 2022 of its H-Guard
® Priming Solution to reduce the life-threatening inflammatory effects of haemodialysis.
Led by Richard Boyd, Chief Executive Officer, Invizius is a late pre-clinical-stage biotechnology company developing treatments to suppress unwanted innate immune responses, focused initially on reducing the life-threatening inflammatory effects of dialysis. Founded in 2017, the University of Edinburgh spin-out is de